# Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells

> **NCT01575470** · PHASE1,PHASE2 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 25 (actual)

## Conditions studied

- Traumatic Brain Injury

## Interventions

- **BIOLOGICAL:** autologous bone marrow mononuclear cells

## Key facts

- **NCT ID:** NCT01575470
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01575470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01575470, "Treatment of Severe Adult Traumatic Brain Injury Using Bone Marrow Mononuclear Cells". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01575470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
